Lebel, E., Asherie, N., Kfir-Erenfeld, S., Avni, B., Grisariu, S., Elias, S., Zimran, E., Vainstein, V., Aumann, S., Assayag, M., Krizhevskaya, M., Dikhter, E., Pick, M., Cohen, Y., Avivi, I., Cohen, C., Gatt, M., Stepensky, P. (2025). Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-2379